CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Ann: Change of Director's Interest Notice, page-5

  1. 459 Posts.
    lightbulb Created with Sketch. 240
    Yes it's becoming more apparent than ever the first priority for these guys is don't spend much and live off average EPP growth. No wonder the market is making a severe adjustment to the PE ratio. Surely they know there's a clock ticking!?!?!
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.